优化儿童喘管理:实施和评估抗炎缓解剂和单一维护和缓解剂疗法
Thinh H Nguyen1, Megan Elios2, Anne M Fitzpatrick3
1Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston.
概括
抗炎缓解剂 (AIR) 和单次维护和缓解剂 (SMART) 疗法在儿童喘中表现有前途. 本综述探讨了它们在幼儿中的风险,益处和挑战,旨在改善喘管理.
科学领域:
- 儿科肺病学 儿科肺病学
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘是儿童常见的慢性呼吸道疾病.
- 抗炎缓解剂 (AIR) 和单次维护和缓解剂 (SMART) 疗法已用于成人和青少年的喘.
- 在较小的儿童中,AIR和SMART疗法的证据有限.
研究的目的:
- 审查目前关于儿童喘中AIR和SMART疗法的风险和益处的证据.
- 识别应用AIR和SMART疗法对幼儿的挑战.
- 通过使用这些疗法,提出改善儿童喘管理的解决方案.
主要方法:
- 对儿童的AIR和SMART治疗研究的系统文献综述.
- 对儿科患者群体的安全性和疗效数据的分析.
- 识别和分类实施挑战和潜在解决方案.
主要成果:
- 在早期儿童中,AIR和SMART治疗的安全性和有效性的证据仍在不断发展.
- 常见的挑战包括小孩子的剂量,监测和遵守.
- 潜在的解决方案包括量身定制的协议和加强护理人员教育.
结论:
- AIR和SMART疗法有可能改善儿童喘管理.
- 需要进一步的研究,以确定幼儿的安全性和有效性.
- 解决已确定的挑战可以促进这些先进的喘疗法在儿科患者中得到更广泛的采用.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Asthma: Pathogenesis and Management
234
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
234
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Inhaled Medications
200
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
200
COPD: Management Using Bronchodilators and Corticosteroids
125
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
125


